companydata.dkONCONOX ApS: Financial statements 2017
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 547,382 and a net result of DKK 393,163 compared with DKK -14,568 the year before. Equity amounted to DKK 1,058,660. The solvency ratio was 90.6%.
- Gross Profit
- 547,382 kr.
- Profit/Loss
- 393,163 kr.
- Equity
- 1,058,660 kr.
- Total Assets
- 1,168,025 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 547 t. | 393 t. | 1.1 mio. | - |
| 2016 | - | 0 | -15 t. | 995 t. | - |
| 2015 | - | - | 1.5 mio. | 1 mio. | - |
| 2014 | - | - | -50 t. | -93 | - |
| 2013 | - | - | -191 t. | 50 t. | - |
Find more companies like ONCONOX ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
ONCONOX ApS has published its annual report for 2016. Gross profit came to DKK 0, and the net result was DKK -14,568.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.